| scholarly article | Q13442814 |
| P2093 | author name string | M Taylor | |
| M Bashir | |||
| A Macrae | |||
| P Shajahan | |||
| P2860 | cites work | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 |
| Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study | Q33186211 | ||
| Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations | Q34941330 | ||
| Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients | Q35985928 | ||
| Aripiprazole augmentation in treatment-resistant depression | Q36035687 | ||
| Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study | Q42678387 | ||
| Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder | Q44513113 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia | Q44649979 | ||
| Worsening schizoaffective disorder with aripiprazole | Q44960142 | ||
| Aripiprazole in schizophrenia: consensus guidelines. | Q46457342 | ||
| Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients | Q46616432 | ||
| Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
| Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 | ||
| Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy | Q50112124 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 778-783 | |
| P577 | publication date | 2008-02-28 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy | |
| P478 | volume | 22 |
| Q28686885 | Agomelatine in unipolar depression in clinical practice: a retrospective chart review |
| Q37029622 | Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice |
| Q37667320 | Aripiprazole in the treatment of early-onset schizophrenia spectrum disorder: A case series in Korean children and adolescents |
| Q36568895 | Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate |
| Q42279135 | Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection |
| Q43161912 | Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study |
| Q36057820 | Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. |
| Q37375634 | The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice |
Search more.